NO20015070D0 - Paroksetin-hydroklorid-anhydrat - Google Patents

Paroksetin-hydroklorid-anhydrat

Info

Publication number
NO20015070D0
NO20015070D0 NO20015070A NO20015070A NO20015070D0 NO 20015070 D0 NO20015070 D0 NO 20015070D0 NO 20015070 A NO20015070 A NO 20015070A NO 20015070 A NO20015070 A NO 20015070A NO 20015070 D0 NO20015070 D0 NO 20015070D0
Authority
NO
Norway
Prior art keywords
paroxetine hydrochloride
hydrochloride anhydrate
anhydrate
paroxetine
hydrochloride
Prior art date
Application number
NO20015070A
Other languages
English (en)
Other versions
NO20015070L (no
Inventor
Victor Witold Jacewicz
Neal Ward
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27267578&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20015070(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9502297.6A external-priority patent/GB9502297D0/en
Priority claimed from GBGB9503112.6A external-priority patent/GB9503112D0/en
Priority claimed from GBGB9509807.5A external-priority patent/GB9509807D0/en
Publication of NO20015070L publication Critical patent/NO20015070L/no
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO20015070D0 publication Critical patent/NO20015070D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
NO20015070A 1995-02-06 2001-10-18 Paroksetin-hydroklorid-anhydrat NO20015070D0 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9502297.6A GB9502297D0 (en) 1995-02-06 1995-02-06 Novel compound
GBGB9503112.6A GB9503112D0 (en) 1995-02-17 1995-02-17 Novel compound
GBGB9509807.5A GB9509807D0 (en) 1995-05-15 1995-05-15 Novel compounds

Publications (2)

Publication Number Publication Date
NO20015070L NO20015070L (no) 1996-08-07
NO20015070D0 true NO20015070D0 (no) 2001-10-18

Family

ID=27267578

Family Applications (3)

Application Number Title Priority Date Filing Date
NO960472A NO301009B1 (no) 1995-02-06 1996-02-05 Paroksetinhydrokloridanhydrat
NO19970939A NO311519B1 (no) 1995-02-06 1997-02-28 Fremgangsmåte ved fremstilling av paroksetinhydrokloridanhydrat
NO20015070A NO20015070D0 (no) 1995-02-06 2001-10-18 Paroksetin-hydroklorid-anhydrat

Family Applications Before (2)

Application Number Title Priority Date Filing Date
NO960472A NO301009B1 (no) 1995-02-06 1996-02-05 Paroksetinhydrokloridanhydrat
NO19970939A NO311519B1 (no) 1995-02-06 1997-02-28 Fremgangsmåte ved fremstilling av paroksetinhydrokloridanhydrat

Country Status (47)

Country Link
EP (3) EP1136490B1 (no)
JP (2) JP2915338B2 (no)
KR (1) KR100289885B1 (no)
CN (3) CN1289496C (no)
AR (2) AR001982A1 (no)
AT (1) AT407528B (no)
AU (2) AU701518C (no)
BE (1) BE1009112A3 (no)
BG (1) BG62967B1 (no)
BR (1) BR9600534A (no)
CA (4) CA2168829C (no)
CH (3) CH689229A5 (no)
CZ (1) CZ297171B6 (no)
DE (3) DE69621777T2 (no)
DK (2) DK11996A (no)
DZ (1) DZ1989A1 (no)
ES (1) ES2114471B1 (no)
FI (3) FI111544B (no)
FR (1) FR2730232B1 (no)
GR (1) GR1002466B (no)
HK (1) HK59397A (no)
HU (1) HUP9600255A1 (no)
IE (1) IE80500B1 (no)
IL (1) IL117035A (no)
IT (1) IT1289532B1 (no)
LU (1) LU88711A1 (no)
LV (1) LV11618B (no)
MA (1) MA23802A1 (no)
MC (1) MC2411A1 (no)
MX (1) MX9600484A (no)
MY (1) MY132529A (no)
NL (1) NL1002248C2 (no)
NO (3) NO301009B1 (no)
NZ (1) NZ280943A (no)
OA (1) OA10261A (no)
PL (1) PL189247B1 (no)
PT (1) PT101827B (no)
RO (1) RO112426B1 (no)
RU (1) RU2125052C1 (no)
SE (1) SE521084C2 (no)
SG (1) SG43787A1 (no)
SI (2) SI21923B (no)
SK (1) SK283608B6 (no)
TR (1) TR199600096A2 (no)
TW (1) TW503238B (no)
UA (1) UA49796C2 (no)
WO (1) WO1996024595A1 (no)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3882224B2 (ja) 1996-05-31 2007-02-14 旭硝子株式会社 パロキセチンの製造方法
ES2331937T3 (es) * 1996-06-13 2010-01-20 Sumitomo Chemical Company, Limited Derivados de piperidina como intermediarios para la preparacion de paroxetina y procedimiento de preparacion de los mismos.
JP2000514653A (ja) * 1996-07-15 2000-11-07 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー 立体特異的分割のためのエステラーゼのスクリーニングおよびその使用
US5672612A (en) * 1996-09-09 1997-09-30 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
US6638948B1 (en) 1996-09-09 2003-10-28 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
CA2193939C (en) * 1996-12-24 2002-02-12 K.S. Keshava Murthy Useful form of anhydrous paroxetine hydrochloride
US5874447A (en) 1997-06-10 1999-02-23 Synthon B. V. 4-Phenylpiperidine compounds for treating depression
EP0987256B1 (de) * 1997-08-08 2001-10-17 Aventis Pharma Deutschland GmbH Kristallform von N-(4-Trifluormethylphenyl)-5-methylisoxazol-4-carbonsäureamid
GB9726907D0 (en) * 1997-12-19 1998-02-18 Smithkline Beecham Plc Novel compounds
CN1300286A (zh) * 1998-03-16 2001-06-20 史密丝克莱恩比彻姆有限公司 帕罗西丁的晶形
US6699882B2 (en) 1998-03-24 2004-03-02 Smithkline Beecham P.L.C. Paroxetine compositions
GB9806312D0 (en) * 1998-03-24 1998-05-20 Smithkline Beecham Plc Novel formulations
AU2003200534B2 (en) * 1998-03-24 2004-12-02 Smithkline Beecham Plc Paroxetine compositions
JP3796351B2 (ja) 1998-04-13 2006-07-12 住友化学株式会社 パロキセチン塩酸塩無水和物の乾燥方法
GB9812941D0 (en) * 1998-06-16 1998-08-12 Smithkline Beecham Plc Method of treatment
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
ES2138937B1 (es) 1998-07-07 2000-10-01 Medichem Sa Polimorfo de maleato de paroxetina y formulaciones farmaceuticas que lo contienen.
PL345885A1 (en) * 1998-08-07 2002-01-14 Smithkline Beecham Plc Process for the preparation of a non-crystalline anhydrate form of paroxetine hydrochloride
GB9824298D0 (en) * 1998-11-05 1998-12-30 Smithkline Beecham Plc Novel process
GB9826175D0 (en) * 1998-11-28 1999-01-20 Smithkline Beecham Plc Novel process
GB9826176D0 (en) * 1998-11-28 1999-01-20 Smithkline Beecham Plc Novel process
GB9826180D0 (en) * 1998-11-30 1999-01-20 Smithkline Beecham Plc Novel process
WO2000032594A1 (en) * 1998-11-30 2000-06-08 Smithkline Beecham Plc Mixed paroxetine propan-2-ol solvates
GB9826178D0 (en) * 1998-11-30 1999-01-20 Smithkline Beecham Plc Novel process
GB9826171D0 (en) * 1998-11-30 1999-01-20 Smithkline Beecham Plc Novel compounds
GB9826242D0 (en) * 1998-11-30 1999-01-20 Smithkline Beecham Plc Novel process
GB9828767D0 (en) * 1998-12-29 1999-02-17 Smithkline Beecham Plc Novel process
CA2367402C (en) * 1999-03-12 2010-11-23 Basf Aktiengesellschaft Stable pharmaceutical dosage form for paroxetine anhydrate
GB9914583D0 (en) * 1999-06-22 1999-08-25 Smithkline Beecham Plc Novel process
GB9914585D0 (en) * 1999-06-22 1999-08-25 Smithkline Beecham Plc Novel process
GB9919001D0 (en) * 1999-08-12 1999-10-13 Smithkline Beecham Plc Novel process
GB9923446D0 (en) * 1999-10-04 1999-12-08 Smithkline Beecham Plc Novel process
GB9923445D0 (en) * 1999-10-04 1999-12-08 Smithkline Beecham Plc Novel process
GB9923439D0 (en) * 1999-10-04 1999-12-08 Smithkline Beecham Plc Novel process
HU226912B1 (en) * 2000-04-07 2010-03-01 Richter Gedeon Nyrt New paroxetin salt and medicament containing it
WO2002022609A1 (fr) * 2000-09-14 2002-03-21 Asahi Glass Company, Limited Procede de production de sel de paroxetine sensiblement exempt de solvant organique
WO2003072104A1 (en) * 2002-02-22 2003-09-04 Teva Pharmaceutical Industries Ltd. Preparation of paroxetine involving novel intermediates
KR20080055990A (ko) * 2005-11-22 2008-06-19 테바 파마슈티컬 인더스트리즈 리미티드 시나칼셋 ＨＣｌ의 결정형 및 이의 제조 방법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
GB8430581D0 (en) * 1984-12-04 1985-01-09 Ferrosan As Treatment
EP0223403B1 (en) * 1985-10-25 1993-08-04 Beecham Group Plc Piperidine derivative, its preparation, and its use as medicament
GB8626936D0 (en) * 1986-11-11 1986-12-10 Ferrosan As Treatment
DK716088D0 (da) * 1988-12-22 1988-12-22 Ferrosan As Reduktion af piperidin-dion-derivater samt intermediat
DK715988D0 (da) * 1988-12-22 1988-12-22 Ferrosan As Etherifikation og dealkylering af piperidin-derivater samt intermediater
KR930702000A (ko) * 1990-11-24 1993-09-08 데이빗 로버츠 노년기 치매, 식용항진, 편두통, 또는 식용불량의 치료를 위한 파로세틴의 사용
GB9325644D0 (en) * 1993-12-15 1994-02-16 Smithkline Beecham Plc Novel formulation

Also Published As

Publication number Publication date
SI9600036B (sl) 2006-12-31
EP1136490B1 (en) 2004-01-07
EP1378508A1 (en) 2004-01-07
CH689229A5 (de) 1998-12-31
PT101827A (pt) 1996-09-30
PL312646A1 (en) 1996-08-19
CN1143643A (zh) 1997-02-26
NO301009B1 (no) 1997-09-01
LV11618B (en) 1997-04-20
NZ280943A (en) 1997-01-29
CA2168829C (en) 1997-12-16
TW503238B (en) 2002-09-21
KR960031409A (ko) 1996-09-17
JPH11228571A (ja) 1999-08-24
AR036856A2 (es) 2004-10-06
FI111544B (fi) 2003-08-15
RU2125052C1 (ru) 1999-01-20
BG100333A (bg) 1996-08-30
MA23802A1 (fr) 1996-10-01
HU9600255D0 (en) 1996-03-28
MX198371B (no) 2000-08-29
EP0808314A1 (en) 1997-11-26
MX9600484A (es) 1997-01-31
CA2168829A1 (en) 1996-08-07
SI9600036A (en) 1996-10-31
GR1002466B (el) 1996-11-06
DE69621777T2 (de) 2003-01-02
IE80500B1 (en) 1998-08-12
CH689804A5 (de) 1999-11-30
DE69631298D1 (de) 2004-02-12
CH688353A5 (de) 1997-08-15
AU4786496A (en) 1996-08-27
CZ32096A3 (en) 1996-08-14
NL1002248C2 (nl) 1996-09-11
BE1009112A3 (fr) 1996-11-05
ES2114471B1 (es) 1999-08-16
ES2114471A1 (es) 1998-05-16
FR2730232A1 (fr) 1996-08-09
KR100289885B1 (ko) 2001-05-15
AU701518C (en) 2006-12-07
AT407528B (de) 2001-04-25
CN1216055C (zh) 2005-08-24
EP0808314B1 (en) 2002-06-12
HUP9600255A1 (en) 1997-03-28
ATA21096A (de) 2000-08-15
CZ297171B6 (cs) 2006-09-13
CN1289496C (zh) 2006-12-13
NO970939D0 (no) 1997-02-28
FI960519A (fi) 1996-08-07
AR001982A1 (es) 1998-01-07
DE69631298T2 (de) 2004-11-18
SK283608B6 (sk) 2003-10-07
SI21923A (sl) 2006-06-30
LU88711A1 (fr) 1996-08-23
FI960519A0 (fi) 1996-02-05
MC2411A1 (fr) 1996-12-02
NL1002248A1 (nl) 1996-08-06
CN1636993A (zh) 2005-07-13
FI20030370A (fi) 2003-03-12
IL117035A (en) 2000-02-29
AU701518B2 (en) 1999-01-28
WO1996024595A1 (en) 1996-08-15
SE521084C2 (sv) 2003-09-30
UA49796C2 (uk) 2002-10-15
IE960104A1 (en) 1996-08-07
RO112426B1 (ro) 1997-09-30
DE69621777D1 (de) 2002-07-18
LV11618A (lv) 1996-12-20
JP2915338B2 (ja) 1999-07-05
DE19603797A1 (de) 1996-08-14
PT101827B (pt) 1997-08-29
CA2211522C (en) 1999-12-07
AU4332896A (en) 1996-08-15
HK59397A (en) 1997-05-16
FR2730232B1 (fr) 1997-08-01
FI20030162A (fi) 2003-02-03
SE9600406L (sv) 1996-08-07
PL189247B1 (pl) 2005-07-29
NO20015070L (no) 1996-08-07
BG62967B1 (bg) 2000-12-29
DK200100223A (no) 2001-02-12
DE19603797C2 (de) 1998-11-12
DK11996A (da) 1996-08-07
DZ1989A1 (fr) 2002-10-15
TR199600096A2 (tr) 1996-08-21
CA2210022A1 (en) 1996-08-07
IL117035A0 (en) 1996-09-12
ITMI960203A1 (it) 1997-08-05
ITMI960203A0 (no) 1996-02-05
CN1090187C (zh) 2002-09-04
SK14396A3 (en) 1996-11-06
CA2210022C (en) 2005-09-13
SI21923B (sl) 2006-12-31
NO970939L (no) 1996-08-07
NO301009B3 (no) 2003-01-06
IT1289532B1 (it) 1998-10-15
CA2210023C (en) 1999-02-09
NO311519B1 (no) 2001-12-03
SE9600406D0 (sv) 1996-02-05
EP1136490A1 (en) 2001-09-26
BR9600534A (pt) 1997-05-13
OA10261A (en) 1997-09-19
NO960472L (no) 1996-08-07
CA2211522A1 (en) 1996-08-07
MY132529A (en) 2007-10-31
CN1310180A (zh) 2001-08-29
JPH08245620A (ja) 1996-09-24
NO960472D0 (no) 1996-02-05
CA2210023A1 (en) 1996-08-07
SG43787A1 (en) 1997-11-14

Similar Documents

Publication Publication Date Title
NO20015070D0 (no) Paroksetin-hydroklorid-anhydrat
DE69631390D1 (de) Substituierte Benzylaminpiperidin-Verbindungen
BR9509997A (pt) Antagonista de taquiquinina
ATE271543T1 (de) N-substituierte 2-cyanopyrrolidine
EE9600186A (et) Neurokiniini (tahhüülkiniini) antagonistid
ATE251155T1 (de) Paroxetinmethansulfonat-acetonitrilsolvat 1:1
DE69606721D1 (de) 1-(5-isochinolinsulfonyl)homopiperazin hydrochlorid
BR9609857A (pt) Composições de paroxetina de liberação controlada
DE69826891D1 (de) Piperidinderivate
NO993460D0 (no) Paroxetine-preparater
NO991564D0 (no) N-substituerte azaheterosykliske forbindelser
DE69732715D1 (de) Tachykinin antagoniste
BR9503042A (pt) Composto de polialquilpiperidina
DE59601292D1 (de) Schutzplankenanordnung
DK0846683T3 (da) 4-hydroxypiperidinderivater
ATA93795A (de) Befestigungsbinder
NO992302L (no) Piperidin-derivater
DE69626503D1 (de) Bohrvorrichtung
DE29513261U1 (de) Bohrlehre
DE29605747U1 (de) Bohrlehre
DE69616456T2 (de) Drillmaschine
DE29513799U1 (de) Bestückautomat
DE29504342U1 (de) Bohrkopf
AU740561C (en) Paroxetine hydrochloride anhydrate
NO20001778D0 (no) Substituerte piperidinderivater

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application